JHS SVEND. LAB. LTD (JHS) financials

JHS SVEND. LAB. LTD (JHS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing oforal and dental products for national and international brands[1]

Market Cap: ₹78.8Cr.
Current Price: ₹9.02
ROE: -1.17%
ROCE: -0.84%
Book Value: ₹20.0
Dividend Yield: 0.00%
52W High / Low: ₹13.9/6.15

In Jun 2026, JHS SVEND. LAB. LTD (JHS) reported sales ₹30.38 Cr and net profit ₹1.09 Cr.

Annual TTM: sales ₹109 Cr, net profit ₹-2 Cr.

Shareholding: Promoters 33.85% (Sep 2026), FIIs 2.87% (Sep 2026), DIIs 0.00% (Sep 2026), Public 63.29% (Sep 2026), No. of Shareholders 25,191% (Sep 2026).

JHS quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	19.68	22.66	25.17	23.45	22.28	23.27	32.70	30.38
Expenses	20.52	22.41	30.55	21.79	21.37	21.60	34.33	28.31
Operating Profit	-0.84	0.25	-5.38	1.66	0.91	1.67	-1.63	2.07
OPM %	-4.27%	1.10%	-21.37%	7.08%	4.08%	7.18%	-4.98%	6.81%
Other Income	0.86	0.27	-1.44	1.00	1.14	0.59	0.73	0.09
Interest	0.11	0.13	0.21	0.16	0.20	0.28	0.22	0.28
Depreciation	1.98	1.97	2.02	1.88	1.86	1.90	1.86	1.82
Profit before tax	-2.07	-1.58	-9.05	0.62	-0.01	0.08	-2.98	0.06
Tax %	398.07%	15.82%	-23.09%	-69.35%	1,800.00%	-887.50%	19.80%	-1,716.67%
Net Profit	-10.32	-1.84	-6.96	1.06	-0.20	0.79	-3.57	1.09
EPS in Rs	-1.21	-0.21	-0.81	0.12	-0.02	0.09	-0.41	0.12
Raw PDF	—	—	—	—	—	—	—	—

JHS profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	133	97	80	85	71	92	102	109
Expenses	123	93	80	94	72	96	99	106
Operating Profit	9	4	0	-9	-1	-4	3	3
OPM %	7%	3.8%	0.2%	-11%	-1.3%	-4.3%	2.6%	2.8%
Other Income	1	6	8	-7	4	0	3	3
Interest	1	0	0	1	0	1	1	1
Depreciation	7	6	6	6	6	8	8	7
Profit before tax	2	3	2	-23	-3	-12	-2	-3
Tax %	1%	13%	228%	-24%	18%	58%	-16%	—
Net Profit	2	3	-2	-18	-4	-20	-2	-2
EPS in Rs	0.29	0.43	-0.38	-2.70	-0.52	-2.31	-0.22	-0.22
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

JHS balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	61	61	64	65	78	78	86	87
Reserves	119	121	127	125	96	92	88	88
Borrowings	7	3	2	2	3	5	6	15
Other Liabilities	33	46	21	19	39	22	25	27
Total Liabilities	220	230	215	211	215	197	204	216
Fixed Assets	69	58	59	55	65	90	90	89
CWIP	5	7	9	16	9	1	0	4
Investments	15	17	14	15	3	3	4	5
Other Assets	130	148	133	125	139	103	110	118
Total Assets	220	230	215	211	215	197	204	216

JHS cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-10	15	15	-11	23	-9	-5	-3
Cash from Investing Activity	1	-7	-6	-1	10	-22	-20	-12
Cash from Financing Activity	4	-8	6	0	-1	2	23	11
Net Cash Flow	-5	-0	16	-12	32	-28	-2	-3
Free Cash Flow	-13	7	7	-14	21	-33	-14	-15
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-115%	158%	436%	-6,094%	-256%	949%	117%	-77%

JHS shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	34.56%	34.56%	34.56%	34.56%	34.56%	33.85%	33.85%	33.85%
FIIs	1.59%	1.60%	1.59%	1.57%	1.57%	3.60%	3.14%	2.87%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	63.85%	63.84%	63.86%	63.87%	63.86%	62.57%	63.03%	63.29%
No. of Shareholders	26,276	25,567	25,155	25,007	25,151	25,330	25,150	25,191

JHS key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	171	262	221	74	80	66	52	60
Inventory Days	51	19	76	104	128	176	151	156
Days Payable	134	179	126	147	221	197	140	174
Cash Conversion Cycle	88	101	171	31	-13	46	63	42
Working Capital Days	168	188	246	287	42	51	47	45
ROCE %	4%	7%	2%	1%	-2%	-2%	-5%	-1%

JHSUpdated 18 Oct 2026, 5:35

Jhs Svend. Lab. Ltd

JHSUpdated 18 Oct 2026, 5:35

Market Cap

₹78.8Cr.

Current Price

₹9.02

High / Low

₹13.9/6.15

ROE-1.17%

ROCE-0.84%

Book Value₹20.0

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing oforal and dental products for national and international brands[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	15.9	0.13	18.02	0.41	1.32	-3.16	-18.35	-2.59	-0.4
Sep 2023	18.93	0.1	18.52	0.2	1.5	-0.99	-26.26	-0.73	-0.09
Dec 2023	14.3	0.11	14.35	2.34	1.63	0.55	98.18	0.01	0
Mar 2024	21.66	0.13	20.82	1.37	1.9	0.18	516.67	-0.75	-0.1
Jun 2024	24.48	0.12	22.51	0.32	1.97	0.2	415	-0.63	-0.08
Sep 2024	19.68	0.11	20.52	0.86	1.98	-2.07	398.07	-10.32	-1.21
Dec 2024	22.66	0.13	22.41	0.27	1.97	-1.58	15.82	-1.84	-0.21
Mar 2025	25.17	0.21	30.55	-1.44	2.02	-9.05	-23.09	-6.96	-0.81
Jun 2025	23.45	0.16	21.79	1	1.88	0.62	-69.35	1.06	0.12
Sep 2025	22.28	0.2	21.37	1.14	1.86	-0.01	1800	-0.2	-0.02
Dec 2025	23.27	0.28	21.6	0.59	1.9	0.08	-887.5	0.79	0.09
Mar 2026	32.7	0.22	34.33	0.73	1.86	-2.98	19.8	-3.57	-0.41
Jun 2026	30.38	0.28	28.31	0.09	1.82	0.06	-1716.67	1.09	0.12

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	55	0	59	-6	12	-22	0	-22	-9.19
Mar 2016	100	0	93	-17	10	-22	0	-22	-5.75
Mar 2017	104	1	92	0	6	5	-326	22	4.98
Mar 2018	138	1	122	32	7	41	32	28	4.61
Mar 2019	120	1	111	5	7	5	31	4	0.59
Mar 2020	133	1	123	1	7	2	1	2	0.29
Mar 2021	97	0	93	6	6	3	13	3	0.43
Mar 2022	80	0	80	8	6	2	228	-2	-0.38
Mar 2023	85	1	94	-7	6	-23	-24	-18	-2.7
Mar 2024	71	0	72	4	6	-3	18	-4	-0.52
Mar 2025	92	1	96	0	8	-12	58	-20	-2.31
Mar 2026	102	1	99	3	8	-2	-16	-2	-0.22
TTM	109	1	106	3	7	-3	—	-2	-0.22

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	33.85%
FIIs	2.87%
Public	63.29%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	37.73%	0%	9.16%	53.1%
Mar 2024	37.73%	2.29%	6.21%	53.75%
Jun 2024	37.73%	0.15%	6.05%	56.05%
Sep 2024	34.56%	1.69%	0%	63.76%
Dec 2024	34.56%	1.59%	0%	63.85%
Mar 2025	34.56%	1.6%	0%	63.84%
Jun 2025	34.56%	1.59%	0%	63.86%
Sep 2025	34.56%	1.57%	0%	63.87%
Dec 2025	34.56%	1.57%	0%	63.86%
Mar 2026	33.85%	3.6%	0%	62.57%
Jun 2026	33.85%	3.14%	0%	63.03%
Sep 2026	33.85%	2.87%	0%	63.29%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	24	78	19	33	153	108	0	0	46	153
Mar 2016	38	63	2	19	123	65	1	0	57	123
Mar 2017	44	91	2	19	156	65	1	1	89	156
Mar 2018	61	116	2	26	205	71	0	18	116	205
Mar 2019	61	119	7	33	220	69	5	15	130	220
Mar 2020	61	121	3	46	230	58	7	17	148	230
Mar 2021	64	127	2	21	215	59	9	14	133	215
Mar 2022	65	125	2	19	211	55	16	15	125	211
Mar 2023	78	96	3	39	215	65	9	3	139	215
Mar 2024	78	92	5	22	197	90	1	3	103	197
Mar 2025	86	88	6	25	204	90	0	4	110	204
Mar 2026	87	88	15	27	216	89	4	5	118	216

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	7	1	-10	-1
Mar 2016	-6	4	4	2
Mar 2017	-4	-3	10	3
Mar 2018	13	-27	14	0
Mar 2019	-10	1	4	-5
Mar 2020	15	-7	-8	0
Mar 2021	15	-6	6	16
Mar 2022	-11	-1	0	-12
Mar 2023	23	10	-1	32
Mar 2024	-9	-22	2	-28
Mar 2025	-5	-20	23	-2
Mar 2026	-3	-12	11	-3

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82	25	48	113	171	262	221	74	80	66	52	60
Inventory Days	94	53	96	59	51	19	76	104	128	176	151	156
Days Payable	106	67	125	123	134	179	126	147	221	197	140	174
Cash Conversion Cycle	70	12	19	48	88	101	171	31	-13	46	63	42
Working Capital Days	-158	58	48	128	168	188	246	287	42	51	47	45
ROCE %	-14%	-3%	5%	9%	4%	7%	2%	1%	-2%	-2%	-5%	-1%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of JHS SVEND. LAB. LTD (JHS)?

The reported market capitalisation for JHS SVEND. LAB. LTD (JHS) is ₹78.8Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of JHS?

The current price shown for JHS SVEND. LAB. LTD (JHS) on Fincrux is ₹9.02 with a 52-week high/low of ₹13.9/6.15.

What were JHS latest quarterly results?

For Jun 2026, JHS SVEND. LAB. LTD (JHS) reported sales ₹30.38 Cr and net profit ₹1.09 Cr (figures in ₹ crore unless noted).

What are JHS annual sales and net profit?

For TTM, JHS SVEND. LAB. LTD (JHS) shows sales of ₹109 Cr and net profit of ₹-2 Cr on the Fincrux profit & loss statement.

Who owns JHS SVEND. LAB. LTD (JHS)?

Latest shareholding for JHS SVEND. LAB. LTD (JHS) on Fincrux: Promoters 33.85% (Sep 2026), FIIs 2.87% (Sep 2026), DIIs 0.00% (Sep 2026), Public 63.29% (Sep 2026), No. of Shareholders 25,191% (Sep 2026).

Where can I find JHS SVEND. LAB. LTD (JHS) financials?

JHS SVEND. LAB. LTD (JHS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show JHS balance sheet and cash flow?

Yes. The JHS SVEND. LAB. LTD (JHS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:35